Posts Tagged ‘drug

October 31, 2022
Our Take: Centene to switch PBMs in 2024, awarding new contract to Express Scripts
Read More
October 24, 2022
Our Take: Analysts predict Apple will enter the health insurance market in 2024, Forbes reports
Read More
October 17, 2022
Our Take: Ransomware attack continues to disrupt business at CommonSpirit
Read More
October 10, 2022
Our Take: Amylyx’s investigational ALS drug gains FDA approval, but the controversy continues
Read More
October 03, 2022
Our Take: Eisai, Biogen’s lecanemab slowed clinical decline by 27% in Phase III Alzheimer’s trial
Read More
September 26, 2022
Our Take: Humana to acquire primary care centers opened in private equity JV for up to $550 million
Read More
September 19, 2022
Our Take: Physician burnout increased in the pandemic’s second year, survey indicates
Read More
September 12, 2022
Our Take: CVS Health wins bidding contest with offer to acquire Signify Health for approximately $8 billion
Read More
August 29, 2022
Our Take: Amazon takes a U-turn and decides to shut down Amazon Care
Read More
August 22, 2022
Our Take: Health systems continue to report dismal financial results in Q2, blunted by labor expenses and poor investment performance
Read More
August 15, 2022
Our Take: HCA Healthcare partners with J&J to improve health equity, patient outcomes, support for nurses
Read More
August 08, 2022
Our Take: CVS could make major primary care acquisition by year-end, execs suggest on earnings call
Read More
August 01, 2022
Our Take: Humana to streamline its operations into two units: Insurance Services and CenterWell
Read More
July 25, 2022
Our Take: Amazon plans to acquire primary care provider One Medical for $3.9 billion
Read More

Sign up for Our Take
the weekly strategic brief for Health Care Executives

Reach out to us

Gainey Corporate Center
8777 N Gainey Center Dr, Ste 205
Scottsdale, AZ 85258
(480) 923-0802

Sign up for Our Take
the weekly strategic brief for Health Care Executives

[contact-form-7 id="321" title="Footer Newsletter"]

Posts Tagged ‘drug

Our Take: Centene to switch PBMs in 2024, awarding new contract to Express Scripts

Our Take: Analysts predict Apple will enter the health insurance market in 2024, Forbes reports

Our Take: Ransomware attack continues to disrupt business at CommonSpirit

Our Take: Amylyx’s investigational ALS drug gains FDA approval, but the controversy continues

Our Take: Eisai, Biogen’s lecanemab slowed clinical decline by 27% in Phase III Alzheimer’s trial

Our Take: Humana to acquire primary care centers opened in private equity JV for up to $550 million

Our Take: Physician burnout increased in the pandemic’s second year, survey indicates

Our Take: CVS Health wins bidding contest with offer to acquire Signify Health for approximately $8 billion

Our Take: Amazon takes a U-turn and decides to shut down Amazon Care

Our Take: Health systems continue to report dismal financial results in Q2, blunted by labor expenses and poor investment performance

Our Take: HCA Healthcare partners with J&J to improve health equity, patient outcomes, support for nurses

Our Take: CVS could make major primary care acquisition by year-end, execs suggest on earnings call

Our Take: Humana to streamline its operations into two units: Insurance Services and CenterWell

Our Take: Amazon plans to acquire primary care provider One Medical for $3.9 billion

Sign up for Our Take
the weekly strategic brief for Health Care Executives

share

Reach out to us

Sign up for Our Take
the weekly strategic brief for Health Care Executives

Stay Connected

Posts Tagged ‘drug

Sign up for Our Takethe weekly strategic brief for Health Care Executives

share

Reach out to us

Sign up for Our Takethe weekly strategic brief for Health Care Executives

Stay Connected

Sign up for Our Take
the weekly strategic brief for Health Care Executives

Sign up for Our Take
the weekly strategic brief for Health Care Executives